Sign In
Buy VANI
$1.28
-0.0200 (-1.54%)
At Close: Jun 03, 2026
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its le
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
08:52pm, Monday, 13'th May 2024
Vivani Medical (NASDAQ: VANI ) just reported results for the first quarter of 2024. Vivani Medical reported earnings per share of -12 cents.
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
04:45pm, Monday, 13'th May 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its le
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
08:30am, Tuesday, 26'th Mar 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its le
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
08:00am, Wednesday, 06'th Mar 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug i
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
06:14am, Wednesday, 06'th Mar 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks continue to surge higher. Shares of Ozempic and Wegovy makers Novo Nordisk A/S NYSE: NVO are already up 20% y
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
07:49am, Friday, 01'st Mar 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants,
Vivani Medical (VANI) stock price surged: is it a good buy?
07:25am, Thursday, 29'th Feb 2024
Vivani Medical (NASDAQ: VANI) stock price surged hard this week after the company published positive results of its ongoing weight loss drug trial. The shares surged from about $1 and reached a high o
Why Is Vivani Medical (VANI) Stock Up 300% Today?
01:59pm, Wednesday, 28'th Feb 2024
Little-known emerging biopharmaceutical company Vivani Medical (NASDAQ: VANI ) saw its market value increase dramatically on Wednesday. Catapulting sentiment was the company's weight-loss solution, wh
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug i
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
06:00am, Tuesday, 14'th Nov 2023
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug i
Vivani Medical to Present at BIO Investor Forum
06:00am, Monday, 16'th Oct 2023
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, preclinical-stage biopharmaceutical company that develops novel, long-term dru
Vivani Medical to Present at the Boulder Peptide Symposium
06:00am, Thursday, 07'th Sep 2023
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, preclinical-stage biopharmaceutical company that develops novel, long-term dru
EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, announced today that its
Vivani Medical Reports Second Quarter Financial Results and Provides Business Update
05:45pm, Monday, 14'th Aug 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term dru
